Manufacturing embraces IT as some drugmakers minimize R&D focus

Specialized IT systems, manufacturing execution systems, and data aggregation and analytics tools are coming together as some drugmakers turn their focus to manufacturing and away from R&D. Their objectives are to improve the quality and predictability of supply and to reduce production costs. Story

Suggested Articles

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.

Branded drug sales in China could suffer in the short term as marketing activities for new meds are limited to reduce the risk of contagion.

Korean CDMO Samsung Biologics is expanding and China API maker WuXi STA opened a 30,000-square-foot oligonucleotide manufacturing facility.